Immunogenicity and safety of Havisure TM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study
Susarla, Sai Krishna, Gupta, Madhu, Kheya Ghosh Uttam, Palkar, Sonali, Dhongade, Ashish Ramachandra, K Siva Ram Prasad, Vasudev Rajapantula, Ravi, MD, Pradeep, N, Satish, M, Rajashakar, B C, Sandhya, G, Rajendra, L, Devi Prasad Sahoo, Kanakasapapathy, Anand Kumar
Published in Vaccine (06.10.2023)
Published in Vaccine (06.10.2023)
Get full text
Journal Article
Immunogenicity and safety of HavisureTM vaccine developed by Human Biologicals Institute in healthy subjects of 12 months to 49 years of age: A phase II/III, randomized, single blind, non-inferiority study
Susarla, Sai Krishna, Gupta, Madhu, Uttam, Kheya Ghosh, Palkar, Sonali, Dhongade, Ashish Ramachandra, Siva Ram Prasad, K., Rajapantula, Vasudev, Ravi, M.D., Pradeep, N., Satish, M., Rajashakar, B.C., Sandhya, G., Rajendra, L., Sahoo, Devi Prasad, Kanakasapapathy, Anand Kumar
Published in Vaccine (06.10.2023)
Published in Vaccine (06.10.2023)
Get full text
Journal Article